News Digital health investors getting choosier as sector matures Despite the well-documented retreat from record levels of funding for digital health ven
Podcasts UK pharma leadership and COVID-19: the pharmaphorum podcast The COVID-19 pandemic has forced significant changes on the pharmaceutical industry as companies scramble to protect employees, ensure business continuity and maintain patient access to med
News GSK boosts anti-infectives pipeline with Scynexis antifungal Last year, GSK said it was planning to invest a cool £1 billion in infectious d
R&D Sponsored Trials and tribulations of drug development What does it take to establish new treatments for rare diseases?
